Similar articles

• Mixed cryoglobulinaemia and hepatitis C virus infection.

  Grandinetti F, De Paola L, Prunesti P, Mazzitello G. Grandinetti F, et al. Ital J Gastroenterol Hepatol. 1997 Dec;29(6):579. Ital J Gastroenterol Hepatol. 1997. PMID: 9513839 No abstract available.
• Failure of cyclosporin therapy in type II mixed cryoglobulinemia associated with hepatitis C virus infection.

  Horsmans Y, Tennstedt D, Cornu C, Geubel AP. Horsmans Y, et al. Clin Exp Rheumatol. 1998 Jul-Aug;16(4):514-5. Clin Exp Rheumatol. 1998. PMID: 9706447 No abstract available.
• Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.

  Garini G, Allegri L, Carnevali L, Catellani W, Manganelli P, Buzio C. Garini G, et al. Am J Kidney Dis. 2001 Dec;38(6):E35. doi: 10.1053/ajkd.2001.29291. Am J Kidney Dis. 2001. PMID: 11728995
• Treatment of hepatitis C-virus-related glomerulonephritis.

  Kamar N, Rostaing L, Alric L. Kamar N, et al. Kidney Int. 2006 Feb;69(3):436-9. doi: 10.1038/sj.ki.5000142. Kidney Int. 2006. PMID: 16514428 Review.
• [Effect of IFN treatment for extrahepatic manifestations].

  Matsumori A. Matsumori A. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):569-73. Nihon Rinsho. 2004. PMID: 15359863 Review. Japanese. No abstract available.